An induced pluripotent stem cell line (MUSIi019-A) generated from a patient with distal renal tubular acidosis carrying a compound heterozygous mutation in solute carrier family 4 member 1 (SLC4A1) gene

被引：0

作者：

Kaewboonlert, Narissara ^{[1
,2
]}

Wattanapanitch, Methichit ^{[3
]}

Praditsap, Oranud ^{[4
]}

Deejai, Nipaporn ^{[1
]}

Chanprasert, Chutima ^{[5
]}

Sawasdee, Nunghathai ^{[1
]}

Nettuwakul, Choochai ^{[1
]}

Wanachiwanawin, Wanchai ^{[6
]}

Sritippayawan, Suchai ^{[7
]}

Thamtarana, Prapaporn Jungtrakoon ^{[5
]}

Yenchitsomanus, Pa-thai ^{[1
]}

Rungroj, Nanyawan ^{[4
]}

机构：

[1] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Res Dept, Bangkok, Thailand

[2] Mahidol Univ, Fac Med, Siriraj Hosp, Biomed Sci Program, Bangkok, Thailand

[3] Mahidol Univ, Siriraj Ctr Regenerat Med, Res Dept, Fac Med,Siriraj Hosp, Bangkok, Thailand

[4] Mahidol Univ, Fac Med, Siriraj Hosp, Siriraj Genom, Bangkok, Thailand

[5] Mahidol Univ, Cellular & Mol Biol Diabet Res Grp, Siriraj Hosp, Div Mol Med,Res Dept,Fac Med, Bangkok, Thailand

[6] Mahidol Univ, Fac Med, Siriraj Hosp, Div Hematol,Dept Med, Bangkok, Thailand

[7] Mahidol Univ, Fac Med, Siriraj Hosp, Div Nephrol,Dept Med, Bangkok, Thailand

来源：

STEM CELL RESEARCH | 2023年 / 67卷

关键词：

Distal renal tubular acidosis; Hemolytic anemia; iPSC; SAO;

D O I：

10.1016/j.scr.2023.103043

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Distal renal tubular acidosis (dRTA), a disease characterized by the failure of the distal nephron to secrete acid into the urine, can be caused by mutations in SLC4A1 gene encoding erythroid and kidney anion exchanger 1 (AE1). Here, an induced pluripotent stem cell (iPSC) line was generated from a patient with dRTA and hemolytic anemia carrying compound heterozygous SLC4A1 mutations containing c.1199_1225del (p.Ala400_Ala408del), resulting in Southeast Asian ovalocytosis (SAO), and c.1331C>A (p.Thr444Asn). Peripheral blood mononuclear cells (PBMCs) were reprogrammed using Sendai viral reprogramming. The established iPSC line, MUSIi019-A, exhibited pluripotent property and retained the same mutations observed in the patients.

引用

页数：5

共 50 条

[31] Reprogramming of a human induced pluripotent stem cell line from a Marfan syndrome patient harboring a heterozygous mutation of c.2939G > A in FBN1 gene
Qin, Zhiping
Sun, Liqiang
Sun, Xue
Gao, Xinxuan
Su, Hang
STEM CELL RESEARCH, 2021, 51
[32] Generation of an Alagille Syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi036-A) carrying a heterozygous mutation (p.Cys693*) in the JAG1 gene
Hatim, Omer
Xu, Miao
Pavlinov, Ivan
Linask, Kaari
Beers, Jeanette
Zou, Jizhong
Liu, Chengyu
Rodems, Steven
Baumgartel, Karsten
Gilbert, Melissa A.
Spinner, Nancy B.
Chen, Catherine
Zheng, Wei
STEM CELL RESEARCH, 2024, 77
[33] Generation of an induced pluripotent stem cell line (MUSIi014-A) from an affected member of a family with autosomal dominant diabetes carrying p. L475P mutation in ZYG11A gene associated with a cell cycle arrest in beta-cell
Chanprasert, Chutima
Promnakhon, Nutchanawan
Thongsin, Nontaphat
Suwanpitak, Siriwal
Plengvidhya, Nattachet
Yenchitsommanus, Pa-Thai
Thamtarana, Prapaporn Jungtrakoon
Wattanapanitch, Methichit
STEM CELL RESEARCH, 2022, 60
[34] Establishment of a human induced pluripotent stem cell line, KMUGMCi003-A, from a patient with trichothiodystrophy 1 (TTD1) bearing compound heterozygous missense mutations in the ERCC2 gene
Ura, Hiroki
Togi, Sumihito
Hatanaka, Hisayo
Niida, Yo
STEM CELL RESEARCH, 2022, 64
[35] An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene
Yang, Shu
Cheng, Yu-Shan
Li, Rong
Pradhan, Manisha
Hong, Junjie
Beers, Jeanette
Zou, Jizhong
Liu, Chengyu
Might, Matt
Rodems, Steven
Zheng, Wei
STEM CELL RESEARCH, 2019, 39
[36] Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene
Mura, Manuela
Lee, Yee-ki
Ginevrino, Monia
Zappatore, Rita
Pisano, Federica
Boni, Marina
Dagradi, Federica
Crotti, Lia
Valente, Enza Maria
Schwartz, Peter J.
Tse, Hung-Fat
Gnecchi, Massimiliano
STEM CELL RESEARCH, 2018, 29 : 157 - 161
[37] Generation of an induced pluripotent stem cell line (SDQLCHi044-A) from a patient with autosomal dominant mental retardation type 5 harboring heterozygous mutation in SYNGAP1 gene
Wang, Yanxin
Lv, Yuqiang
Yang, Xiaomeng
Li, Yue
Li, Zilong
Gao, Zaifen
Gai, Zhongtao
Liu, Yi
STEM CELL RESEARCH, 2022, 64
[38] Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene
Huang, Xiuli
Roeder, Amanda
Li, Rong
Beers, Jeanette
Liu, Chengyu
Zou, Jizhong
Yu, Paul B.
Zheng, Wei
STEM CELL RESEARCH, 2021, 54
[39] Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545C > A mutation in DNM1 gene
Xu, Yan
Wang, Xinhua
Qiu, Tian
Wang, Ji
Wang, Yi
Wu, Bingbing
Zhou, Yuanfeng
STEM CELL RESEARCH, 2022, 60
[40] Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene
Tanaka, Yasuyoshi
Higurashi, Norimichi
Shirasu, Naoto
Yasunaga, Shin'ichiro
Moreira, Kevin Mello
Okano, Hideyuki
Hirose, Shinichi
STEM CELL RESEARCH, 2018, 31 : 11 - 15

← 1 2 3 4 5 →